GS3 · Technology

Quantum security chip, 25-qubit processor and CAR-T therapy dedicated to the nation

Battle IAS current affairs title card: Quantum security chip, 25-qubit processor and CAR-T therapy dedicated to the nation (GS3 · Technology, 5 November 2025)
Asked by UPSCPrelims 20261 PYQ

UPSC has already asked about this. Read the story with these questions in mind.

What happened

  • At ESTIC 2025 the PM dedicated three innovations: QSIP, India’s own quantum security chip; a 25-qubit quantum processing unit, described as India’s first quantum computing chip; and an indigenous CAR-T cell therapy for cancer [PIB].
  • NexCAR19 by ImmunoACT, supported by DBT and BIRAC, is described as the world’s first humanised CAR-T therapy developed in India [PIB].

Background

  • NexCAR19 was supported by DBT and BIRAC [PIB].

Why it matters

  • Indigenous CAR-T at a fraction of global cost is a strong example of science serving public health.

How to use this in Mains

GS-III Science and technology: IT, computers, robotics, indigenisation

  1. As per PIB (2025-11-05): at ESTIC 2025 the PM dedicated three innovations: QSIP, India's own quantum security chip; a 25-qubit quantum processing unit, described as India's first quantum computing chip; and an indigenous CAR-T cell therapy for cancer.
  2. Indigenous CAR-T at a fraction of global cost is a strong example of science serving public health.
Quotable data point

NexCAR19 by ImmunoACT, supported by DBT and BIRAC, is described as the world's first humanised CAR-T therapy developed in India.

PIB: MoST: QSIP, 25-qubit QPU and CAR-T therapy, 5 Nov 2025

Exam angle

UPSC

Prelims: CAR-T, qubit.

Practice MCQs

Original practice questions (not PYQs).

Practice · UPSC

QSIP is a

Answer (a) & explanation

PIB.

Practice · UPSC

NexCAR19 was developed by

Answer (a) & explanation

PIB.

Practice · UPSC

CAR-T therapy uses modified

Answer (b) & explanation

PIB.

Go deeper

Official source: PIB: MoST: QSIP, 25-qubit QPU and CAR-T therapy, 5 Nov 2025

facts from cited sources only; faculty review pending